Abstract
L-type calcium channel (LTCC) blockers are used as cardiac antiarrhythmics or antihypertensives. In our previous research, we have reported a furanocoumarin, imperatorin, which exhibited potent vasodilatory effects. The possible mechanism might involve with inhibition against LTCC. In order to further investigate the pharmacologic mechanism of imperatorin for interaction with LTCC, the homology modeling of LTCC was performed using MODELLER 9.9 program with potassium channels as templates. The binding mode of imperatorin to LTCC was further investigated by molecular docking. Molecular docking results indicated that imperatorin occupied the same binding site as verapamil and hydrogen bond interaction played important role in blocker-channel binding. Docking studies provided useful information to understand the action mechanism of imperatorin. The results described here will be helpful in the development of novel potential LTCC blockers.
Keywords: L-type calcium channel, Imperaorin, Homology Modeling, Docking, Cell Membrane Chromatography.
Medicinal Chemistry
Title:Structural Modeling and Identification of Imperatorin as Novel L-type Calcium Channel Blocker
Volume: 9 Issue: 7
Author(s): Wen Lu, Tao Zhang, Pengfei Li, Fang Wang, Xiaoyan Pan, Chen Wang, Zhigang Hu and Jie Zhang
Affiliation:
Keywords: L-type calcium channel, Imperaorin, Homology Modeling, Docking, Cell Membrane Chromatography.
Abstract: L-type calcium channel (LTCC) blockers are used as cardiac antiarrhythmics or antihypertensives. In our previous research, we have reported a furanocoumarin, imperatorin, which exhibited potent vasodilatory effects. The possible mechanism might involve with inhibition against LTCC. In order to further investigate the pharmacologic mechanism of imperatorin for interaction with LTCC, the homology modeling of LTCC was performed using MODELLER 9.9 program with potassium channels as templates. The binding mode of imperatorin to LTCC was further investigated by molecular docking. Molecular docking results indicated that imperatorin occupied the same binding site as verapamil and hydrogen bond interaction played important role in blocker-channel binding. Docking studies provided useful information to understand the action mechanism of imperatorin. The results described here will be helpful in the development of novel potential LTCC blockers.
Export Options
About this article
Cite this article as:
Lu Wen, Zhang Tao, Li Pengfei, Wang Fang, Pan Xiaoyan, Wang Chen, Hu Zhigang and Zhang Jie, Structural Modeling and Identification of Imperatorin as Novel L-type Calcium Channel Blocker, Medicinal Chemistry 2013; 9 (7) . https://dx.doi.org/10.2174/1573406411309070013
DOI https://dx.doi.org/10.2174/1573406411309070013 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Connexins in Renal Endothelial Function and Dysfunction
Cardiovascular & Hematological Disorders-Drug Targets Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy
Current Drug Targets Radial vs Femoral Approach in Acute Coronary Syndromes: A Meta- Analysis of Randomized Trials
Current Vascular Pharmacology Pharmacological Implications of MMP-9 Inhibition by ACE Inhibitors
Current Medicinal Chemistry Recent Advances of Hepsin-Targeted Inhibitors
Current Medicinal Chemistry Synthesis and Preliminary Biological Evaluation of Chrysin Derivatives as Potential Anticancer Drugs
Medicinal Chemistry Role of the APP Non-Amyloidogenic Signaling Pathway and Targeting α-Secretase as an Alternative Drug Target for Treatment of Alzheimers Disease
Current Medicinal Chemistry Resveratrol and Its Analogues: Promising Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Oxidized LDL Antibodies in Treatment and Risk Assessment of Atherosclerosis and Associated Cardiovascular Disease
Current Pharmaceutical Design Computer Aided Systems for Diabetic Retinopathy Detection Using Digital Fundus Images: A Survey
Current Medical Imaging Current Targets for Anticancer Drug Discovery
Current Drug Targets Novel Drugs Targeting the c-Ring of the F<sub>1</sub>F<sub>O</sub>-ATP Synthase
Mini-Reviews in Medicinal Chemistry Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells
Current Molecular Medicine Memory Impairment is Associated with Serum Methylarginines in Older Adults
Current Alzheimer Research Vasculopathy in Hyperthyroid Rats and Targets for Drug Effects
Vascular Disease Prevention (Discontinued) State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies
Current Medicinal Chemistry Electrospinning for Bone Tissue Engineering
Recent Patents on Nanotechnology Scaffolds for Blocking Protein-Protein Interactions
Current Topics in Medicinal Chemistry Microglial dependent protective effects of neuroactive steroids
CNS & Neurological Disorders - Drug Targets Are the Myokines the Mediators of Physical Activity-Induced Health Benefits?
Current Pharmaceutical Design